Effect of co-dergocrine mesylate on tard
โ
Jack Hajioff; Mackenzie Wallace
๐
Article
๐
1983
๐
Springer
๐
English
โ 265 KB
Twenty patients with signs of tardive dyskinesia secondary to antipsychotic medication participated in a double blind, controlled, parallel group study comparing codergocrine mesylate 4.5 mg once daily with a placebo. After 6 weeks medication a reduction in dyskinetic scores occurred in both groups,